Skip to main content
. 2020 Sep 22;58(10):e01669-20. doi: 10.1128/JCM.01669-20

FIG 2.

FIG 2

(A) Agreement between 35 sets of co-collected nasopharyngeal swab, oropharyngeal swab, and nasal swab clinical specimens with positive (+) and negative (–) Aptima SARS-CoV-2 TMA assay results. (B) Scatterplot of corresponding Aptima SARS-CoV-2 TMA assay positive and negative kRLU signal for each sample type.